Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Alzheimer's Disease

Free Subscription 23.03.2026 1 Acta Neuropathol 13 Alzheimers Dement 1 Am J Geriatr Psychiatry 3 Ann Neurol 1 Biochemistry (Mosc) 1 BMJ 1 Brain 1 Brain Res 1 Exp Gerontol 4 Exp Neurol 1 Int J Neurosci 13 J Alzheimers Dis 2 J Am Geriatr Soc 2 J Neural Transm (Vienna) 1 J Neurol Neurosurg Psychiatry 1 JAMA 1 Nat Med 1 Nat Rev Neurol 3 Neurobiol Dis 1 Neurosci Lett 1 PLoS One 2 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Acta Neuropathol

1. SALEEM T, Mobius W, Schmitz M, da Silva Correia A, et al
   A distinct tau oligomer strain defines the molecular and proteomic landscape of rapidly progressive Alzheimer's disease.
   Acta Neuropathol. 2026;151:27.
   PubMed         Abstract available
   
   

   
   Alzheimers Dement

2. DESVARIEUX M, Rundek T, Ahsan H, Narvaez J, et al
   Accelerating real-world prediction and research in Alzheimer's: The M3AD study.
   Alzheimers Dement. 2026;22:e71174.
   PubMed         Abstract available
   
   
3. BAX F, Oltmer J, Auger CA, Bonkhoff A, et al
   APOE-mediated sex differences in microvascular pathology and AD-associated proteinopathies in the medial temporal lobe.
   Alzheimers Dement. 2026;22:e71206.
   PubMed         Abstract available
   
   
4. ZHANG Y, Li Y, Wang Q, Pang J, et al
   Late-life methionine restriction attenuates neuroinflammation in Alzheimer's disease mice via FGF21 activation in a metabolism-independent manner.
   Alzheimers Dement. 2026;22:e71287.
   PubMed         Abstract available
   
   
5. SUN J, Zufiria-Gerboles B, Passaretti M, Volpe G, et al
   Tracking early cognitive decline in preclinical AD with brain MRI similarity.
   Alzheimers Dement. 2026;22:e71170.
   PubMed         Abstract available
   
   
6. KUNDU P, Zhu C, Huentelman M, Deoni SCL, et al
   Brain volume trajectories in young children are associated with polygenic scores for late-onset Alzheimer's disease risk.
   Alzheimers Dement. 2026;22:e71279.
   PubMed         Abstract available
   
   
7. INTRONA A
   ARIAs are not random: A posterior and border-zone vascular vulnerability model.
   Alzheimers Dement. 2026;22:e71304.
   PubMed         Abstract available
   
   
8. RAE RJ, Alberhasky JMH, Baillet M, Bangasser DA, et al
   Sex differences in neuromodulatory subcortical systems and their implications for Alzheimer's disease.
   Alzheimers Dement. 2026;22:e71291.
   PubMed         Abstract available
   
   
9. PIOTROWSKI SL, Allnutt MA, Johnson K, Tanaka T, et al
   Herpesvirus genome integration in whole-genome sequences of dementia and control cohorts.
   Alzheimers Dement. 2026;22:e71047.
   PubMed         Abstract available
   
   
10. PERRY KE, Merenstein J
    From cradle to cortex: An exposome- and equity-centered perspective of neurocognitive aging and dementia risk in the era of climate change.
    Alzheimers Dement. 2026;22:e71158.
    PubMed         Abstract available
    
    
11. FU W, Chao X, Wang Y, Liu S, et al
    Bile acids are associated with baseline and longitudinal amyloid and tau pathology in patients with Alzheimer's disease.
    Alzheimers Dement. 2026;22:e71307.
    PubMed         Abstract available
    
    
12. ZAMANI J, Vahid A, Wilson EN, Hosseini SMH, et al
    Multivariate patterns of plasma biomarkers predict region-specific Alzheimer's pathology and cognitive decline across independent cohorts.
    Alzheimers Dement. 2026;22:e71265.
    PubMed         Abstract available
    
    
13. PEDERSEN TJ, Clemens SG, Winer JR, Sharma A, et al
    Wake-promoting neuromodulators in Alzheimer's disease: Implications for sleep and brain clearance.
    Alzheimers Dement. 2026;22:e71298.
    PubMed         Abstract available
    
    
14. GUTSTEIN DB, Iorga M, Stocks J, Gill N, et al
    Identifying neuropathologic disease in primary progressive aphasia using narrative speech.
    Alzheimers Dement. 2026;22:e71294.
    PubMed         Abstract available
    
    

    
    Am J Geriatr Psychiatry

15. RAJKUMAR G, Uthayakumar H, Khoury MA, Valcic M, et al
    Genetic and Hormonal Contributions to Psychosis Symptoms in Alzheimer's Disease: A Sex-Stratified Analysis.
    Am J Geriatr Psychiatry. 2026 Feb 24:S1064-7481(26)00067.
    PubMed         Abstract available
    
    

    
    Ann Neurol

16. BROWN CA, Cousins KAQ, Korecka M, McGrew E, et al
    Temporal Modeling of Amyloid and Tau Trajectories in Alzheimer's Disease Using PET and Plasma Biomarkers.
    Ann Neurol. 2026 Mar 15. doi: 10.1002/ana.78194.
    PubMed         Abstract available
    
    
17. XU YR, Tao Y, Lish AM, Li S, et al
    Novel Monoclonal Antibody Detects Small Abeta Oligomers More Sensitively Than Lecanemab in Alzheimer's Disease CSF, Serum and Culture Media.
    Ann Neurol. 2026 Mar 16. doi: 10.1002/ana.78196.
    PubMed         Abstract available
    
    
18. TROPEA TF, Stevenson PA, Flitter M, Meehan D, et al
    Association between Plasma P-tau217 and Alzheimer's Copathology and Cognitive Decline in Parkinson's Disease.
    Ann Neurol. 2026 Mar 18. doi: 10.1002/ana.78201.
    PubMed         Abstract available
    
    

    
    Biochemistry (Mosc)

19. ZAGRYADSKAYA YA, Nesterov SV, Mitkevich VA, Kozin SA, et al
    Beta-Amyloid Suppresses Mitochondrial ATP Production in Human Neuroblastoma Cells.
    Biochemistry (Mosc). 2026;91:230-244.
    PubMed         Abstract available
    
    

    
    BMJ

20. IACOBUCCI G
    Alzheimer's drugs: Lecanemab and donanemab to be reconsidered for NHS after appeal.
    BMJ. 2026;392:s551.
    PubMed        
    
    

    
    Brain

21. WEISE CM, Abu-Rumeileh S, Otto M
    From 'senile dementia' to non-vascular Alzheimer's synucleinopathy: the evolution of dementia classification.
    Brain. 2026 Mar 16:awag103. doi: 10.1093.
    PubMed        
    
    

    
    Brain Res

22. MIAO Z, Yang Z, Huang Q, Fan J, et al
    Ding-zhi-xiao-wan attenuates Alzheimer's disease pathology and cognitive deficits in mouse model.
    Brain Res. 2026;1881:150263.
    PubMed         Abstract available
    
    

    
    Exp Gerontol

23. ZAMMIT AR, Gross AL, Yu L, Barnes LL, et al
    Harmonization of late-life participation in cognitively stimulating activities across four cohort studies of cognitive aging.
    Exp Gerontol. 2026;216:113069.
    PubMed         Abstract available
    
    

    
    Exp Neurol

24. LI W, Chen S, Liu Z, Lei B, et al
    Differential effects and underlying mechanisms of voluntary, forced, and combined exercise on ameliorating Alzheimer's disease pathophenotypes.
    Exp Neurol. 2026;401:115731.
    PubMed         Abstract available
    
    
25. ZHU X, Lai X, Deng J, Long Y, et al
    Naturally occurring antibodies against ASC reduced in Alzheimer's disease and alleviating AD-type pathology in APP/PS1 mouse.
    Exp Neurol. 2026 Mar 15:115728. doi: 10.1016/j.expneurol.2026.115728.
    PubMed         Abstract available
    
    
26. ZHAO Y, Chen W, Zhou F
    IL-1beta neutralization ameliorates cognitive deficits and tau pathology in a mouse model of Alzheimer's disease with hyperhomocysteinemia.
    Exp Neurol. 2026;401:115729.
    PubMed         Abstract available
    
    
27. CHEN W, Huang N, Huang W, Wang M, et al
    TREM2 as a possible link between Alzheimer's disease and diabetes mellitus.
    Exp Neurol. 2026 Mar 18:115739. doi: 10.1016/j.expneurol.2026.115739.
    PubMed         Abstract available
    
    

    
    Int J Neurosci

28. RS R, G S G, S S, P A, et al
    Self-Improved LeNet and Modified SegNet for Alzheimer's Disease Classification using MRI.
    Int J Neurosci. 2026 Mar 14:1-24. doi: 10.1080/00207454.2026.2644529.
    PubMed         Abstract available
    
    

    
    J Alzheimers Dis

29. YUAN M, Zhou HY
    CTAD 2025: Key trends redefining therapeutic and diagnostic strategies in Alzheimer's disease.
    J Alzheimers Dis. 2026 Mar 15:13872877261430764. doi: 10.1177/13872877261430764.
    PubMed         Abstract available
    
    
30. JIANG X, Lv G, Xiong X, Yuan J, et al
    Cost-effectiveness of traditional and novel neurotherapeutic agents for Alzheimer's disease: A systematic review.
    J Alzheimers Dis. 2026 Mar 16:13872877261430376. doi: 10.1177/13872877261430376.
    PubMed         Abstract available
    
    
31. HU S, Ge J, Wang G, Zhao M, et al
    Plasma biomarker changes following deep cervical lymphatic venous anastomosis: An exploratory study in Alzheimer's disease using single-molecule array technology.
    J Alzheimers Dis. 2026 Mar 16:13872877261431355. doi: 10.1177/13872877261431355.
    PubMed         Abstract available
    
    
32. KIM MG, Woo SH, Kim GW, Choi HK, et al
    Efficacy and safety of Woohwangchungsimwon in combination with donepezil for behavioral and psychological symptoms of dementia in probable Alzheimer's disease: An assessor-blinded randomized controlled trial.
    J Alzheimers Dis. 2026 Mar 16:13872877261431692. doi: 10.1177/13872877261431692.
    PubMed         Abstract available
    
    
33. GAO P, Chen B, Xu D, Wang Q, et al
    Differential effects of PSEN1 mutations (p.P117L with ataxia and p.P264L without ataxia) in early-onset Alzheimer's disease.
    J Alzheimers Dis. 2026 Mar 16:13872877261430771. doi: 10.1177/13872877261430771.
    PubMed         Abstract available
    
    
34. CHEN YJ, Gaba A, Yang HW, Maher M, et al
    Associations between polygenic risk scores for Alzheimer's disease and postoperative delirium risk.
    J Alzheimers Dis. 2026 Mar 16:13872877261430955. doi: 10.1177/13872877261430955.
    PubMed         Abstract available
    
    
35. MA J, Zhou S, Zhu W, Tao Y, et al
    Periodontitis associated with multi-region brain functional alterations and cognitive impairment: A cross-sectional study in normal cognition, amnestic mild cognitive impairment, and Alzheimer's disease.
    J Alzheimers Dis. 2026 Mar 16:13872877261426906. doi: 10.1177/13872877261426906.
    PubMed         Abstract available
    
    
36. CANET G, Lucey BP, Blessing EM, Planel E, et al
    Lifelong heat exposure as a potential contributor to Alzheimer's disease resilience.
    J Alzheimers Dis. 2026 Mar 18:13872877261433226. doi: 10.1177/13872877261433226.
    PubMed         Abstract available
    
    
37. PANDEY JP, Namboodiri AM, Nietert PJ
    Immunoglobulin allotypes and RELN alleles and humoral immunity to HSV1 in patients with Alzheimer's disease and matched controls.
    J Alzheimers Dis. 2026 Mar 18:13872877261431862. doi: 10.1177/13872877261431862.
    PubMed         Abstract available
    
    
38. MESSAOUDI SA, Alsaleh A, AlSalem LA, Rameshbabu S, et al
    Association of genetic variants in cyclin-dependent kinase 5 with Alzheimer's disease in a Saudi cohort.
    J Alzheimers Dis. 2026 Mar 18:13872877261427358. doi: 10.1177/13872877261427358.
    PubMed         Abstract available
    
    
39. ZHU W, Li H, Wang K, Sun M, et al
    Evidence integration of acupuncture for prevention and treatment of Alzheimer's disease and mild cognitive impairment from a neuroimaging perspective.
    J Alzheimers Dis. 2026 Mar 20:13872877261420235. doi: 10.1177/13872877261420235.
    PubMed         Abstract available
    
    
40. JIAN JM, Li XP, Xie JH, Hu JN, et al
    Chronic high-altitude hypoxia exacerbates cognitive impairment and Alzheimer's disease pathology.
    J Alzheimers Dis. 2026 Mar 20:13872877261431844. doi: 10.1177/13872877261431844.
    PubMed         Abstract available
    
    
41. DAMODARASAMY M, Hernandez GJ, Johnson RS, Keene CD, et al
    Lecanemab alters basement membrane collagen IV in viable microvessels isolated from brains with high Alzheimer's disease neuropathology.
    J Alzheimers Dis. 2026 Mar 20:13872877261433167. doi: 10.1177/13872877261433167.
    PubMed         Abstract available
    
    

    
    J Am Geriatr Soc

42. MILLER-WINDER AP, Relerford RR, Schierer A, Murawski A, et al
    Phenotypes of Older Adults Planning for Alzheimer's Disease Support.
    J Am Geriatr Soc. 2026 Mar 20. doi: 10.1111/jgs.70401.
    PubMed        
    
    
43. REUBEN DB, Chambliss AB, Katz BJ, Lopez AS, et al
    Rational Use of Blood-Based Biomarkers for Alzheimer's Disease: Navigating Between the Hope and the Hype.
    J Am Geriatr Soc. 2026 Mar 19. doi: 10.1111/jgs.70384.
    PubMed         Abstract available
    
    

    
    J Neural Transm (Vienna)

44. HESAROOEYEH ZG, Khalili E, Michel TM, Vafaee MS, et al
    The pathogenic role of gut microbiota dysbiosis in Alzheimer's disease: a narrative review of neuroimaging evidence.
    J Neural Transm (Vienna). 2026 Mar 14. doi: 10.1007/s00702-026-03126.
    PubMed        
    
    
45. LEAVITT VM, Simani L, Haghighi AB, Koch M, et al
    Language dysfunction as a primary feature of cognitive decline in neurological populations.
    J Neural Transm (Vienna). 2026;133:397-407.
    PubMed         Abstract available
    
    

    
    J Neurol Neurosurg Psychiatry

46. PEROVNIK M, Simoncic U, Jamsek J, Gregoric Kramberger M, et al
    Metabolic brain networks in dementia with Lewy bodies: from prodromal to manifest disease stages.
    J Neurol Neurosurg Psychiatry. 2026;97:316-324.
    PubMed         Abstract available
    
    

    
    JAMA

47. RUBIN R
    Lithium for Alzheimer Disease-Pilot Study Sets the Stage for Larger Trials.
    JAMA. 2026 Mar 20. doi: 10.1001/jama.2026.3046.
    PubMed        
    
    

    
    Nat Med

48. 
    A biomarker of Alzheimer's disease could be a useful diagnostic tool for other amyloidoses.
    Nat Med. 2026 Mar 19. doi: 10.1038/s41591-026-04336.
    PubMed        
    
    

    
    Nat Rev Neurol

49. DUZEL E, Kreutz MR
    Maintaining and regaining episodic memory in Alzheimer disease: a circuit-based perspective.
    Nat Rev Neurol. 2026 Mar 16. doi: 10.1038/s41582-026-01189.
    PubMed         Abstract available
    
    

    
    Neurobiol Dis

50. HUANG J, Rehman H, Doan C, Stein TD, et al
    Corrigendum to 'Circulating C-reactive protein influences polygenic risk of inflammatory genes expressed in brain endothelia for Alzheimer's disease' Neurobiology of Disease 219 (2026) Article Number 107257.
    Neurobiol Dis. 2026 Mar 16:107348. doi: 10.1016/j.nbd.2026.107348.
    PubMed        
    
    
51. GIUFFRE GM, Scalese A, Quaranta D, Donnarumma F, et al
    The impact of insulin resistance on cognitive impairment and cerebrospinal fluid biomarkers in Alzheimer's disease.
    Neurobiol Dis. 2026;222:107352.
    PubMed         Abstract available
    
    
52. CHENG B, Cheng S, Wei W, Pan C, et al
    Residential green space, natural environment, domestic garden, and the risk of Parkinson's disease: A prospective cohort study.
    Neurobiol Dis. 2026 Feb 25:107334. doi: 10.1016/j.nbd.2026.107334.
    PubMed         Abstract available
    
    

    
    Neurosci Lett

53. WANG C, Li J, Liu Q, Yang R, et al
    Retraction notice to "Hydrogen-rich saline reduces oxidative stress and inflammation by inhibit of JNK and NF-kappaB activation in a rat model of amyloid-beta-induced Alzheimer's disease" [Neurosci. Lett. 491 (2011) 127-132].
    Neurosci Lett. 2026 Mar 12:138574. doi: 10.1016/j.neulet.2026.138574.
    PubMed        
    
    

    
    PLoS One

54. SIAM MBH, Khan MR, Elahe MF, Arman MS, et al
    Effects of similarity networks in graph-based multi-omics classification.
    PLoS One. 2026;21:e0344754.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

55. 
    Correction for Chen et al., RNA-binding activity of PHGDH drives amyloid-beta production in a human brain organoid model of sporadic Alzheimer's disease.
    Proc Natl Acad Sci U S A. 2026;123:e2606894123.
    PubMed        
    
    
56. FISCHER CM, Edu IA, Sneideris T, Baronaite I, et al
    Reversibility and beta-sheet formation are decoupled in tau condensate aging.
    Proc Natl Acad Sci U S A. 2026;123:e2522993123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Alzheimer's Disease is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum